FATE icon

Fate Therapeutics

157 hedge funds and large institutions have $362M invested in Fate Therapeutics in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 59 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

7% less funds holding

Funds holding: 169157 (-12)

27% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 37

31% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 59

Holders
157
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$101K
Puts
$40K
Net Calls
Net Calls Change

Top Buyers

1 +$12.8M
2 +$6.36M
3 +$4.54M
4
IHAM
Integral Health Asset Management
New York
+$3.37M
5
Citigroup
Citigroup
New York
+$3.12M

Top Sellers

1 -$6.04M
2 -$4.76M
3 -$4.38M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.23M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.47M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$49.3M
2
$41.9M
3
$34.8M
4
$18.1M
5
$13.4M
6
$13M
7
$12.6M
8
$9.97M
9
$9.88M
10
$9.79M
11
$8.53M
12
$8.17M
13
$7.75M
14
$7.67M
15
$7.02M
16
$6.97M
17
$6.96M
18
$6.92M
19
$6.36M
20
$5.8M
21
$4.82M
22
$3.68M
23
$3.37M
24
$3.36M
25
$3.34M